65,437 trials
Non-small Cell Lung Cancer
Primary: Progression Free Survival — 4.6; 3.4 months
Asthma
Primary: Mean Area Under the Concentration Time Curve Over the Dosing Period (AUC[0-tau]) for FP — 376.9; 573.1; 350.5; 559.1 Picogram hours per milliliter (pg*h/mL)
Seasonal Allergic Rhinitis · Hay Fever
Primary: Change From Baseline in Average Subject-Reported AM and PM Reflective Total Nasal Symptom Score (rTNSS) Over the Two-week Treatment Period — -2.0; -1.0 units on a scale…
Rhinitis, Allergic, Perennial
Primary: Change From Baseline in Average Subject-Assessed 24-Hour Reflective Total Nasal Symptom Score (rTNSS) up to 30 Weeks — -3.4; -2.4 units on a scale — p=<0.001
Chronic Obstructive Pulmonary Disease
Primary: Percentage of Participants With Maximum Heart Rate Increase During Exercise in Part 1 of the Study — 20.00; 16.0 Percentage of participants
Major Depressive Disorder · Treatment Resistant Depression
Primary: Change in Depressive Symptoms Between Randomisation and Week 6 Measured by Change in Montgomery Asberg Depression Rating Scale (MADRS) Total Score (Per Protocol Analysis…
Labor
Primary: Time to Delivery (by Any Route) — 10.43; 11.23 Hours — p=.42
Gaucher Disease Type 1
Primary: Liver Volume at Baseline and at End of Treatment — 1774.6; 1727.1 cm^3
Rhinitis, Allergic, Perennial
Primary: Change From Baseline in Average AM and PM Reflective Total Nasal Symptom Score (rTNSS) Over the Six-week Treatment Period — -2.5; -1.6 units on a scale — p=<0.001
Liberation From Mechanical Ventilation
Primary: Total Days of Mechanical Ventilatory Support — 6.51; 4.02 days
Infections, Meningococcal
Primary: Serum Bactericidal Assay (Performed Using Baby Rabbit Complement) for Neisseria Meningitidis Serogroups A, C, W-135 and Y (rSBA-MenA, rSBA-MenC, rSBA-MenW-135 and…
Non-Small-Cell Lung Carcinoma · Adenocarcinoma
Primary: Progression Free Survival (PFS) — 5.7; 6.1 Months — p=0.639
Lymphoma · Leukemia
Primary: 6-month Treatment Related Mortality (TRM)
Seasonal Allergic Rhinitis · Hayfever
Primary: Change From Baseline in Average AM and PM Reflective Total Nasal Symptom Score (rTNSS) Over the Two-week Treatment Period — -1.88; -1.87; -2.22; -1.59 units on a scale…
Influenza
Primary: Haemagglutination Inhibition (HI) Antibody Titers for the H1N1 Vaccine Strain — 37.9; 40.1; NA; NA titer